Now I have enough information from multiple authoritative sources. Here is the complete answer:
Tests for Nyctalopia (Night Blindness)
Nyctalopia is the inability to see adequately in dim light or darkness, caused by dysfunction of rod photoreceptors, which depend on rhodopsin (a vitamin A-derived photopigment). Testing aims to confirm the presence of night blindness, quantify severity, and identify the underlying cause.
1. History and Symptom Assessment (First Step)
- Difficulty driving at night
- Trouble adjusting when entering a dark room from bright light
- Recurrent nighttime falls
- Ask about dietary history (vitamin A deficiency), medications (phenothiazines, chloroquine), and family history (hereditary dystrophies)
2. Dark Adaptation Testing (Most Direct Test)
Dark Adaptometry is the gold-standard functional test for nyctalopia.
Principle: The retinal photoreceptors are first "bleached" by bright light exposure, then the patient is placed in darkness. The threshold of light detection is measured repeatedly over time, plotting the dark adaptation curve.
- Normal curve: Shows a biphasic response - initial cone-mediated adaptation (faster, first 5-10 min) followed by rod-mediated adaptation (slower, 20-40 min), producing the characteristic "Kohlrausch kink"
- Abnormal: Elevated final threshold, delayed or absent rod segment, or complete absence of the biphasic curve
Instruments:
- Goldmann-Weekers Adaptometer - classic laboratory standard
- AdaptDx / AdaptDx Pro (MacuLogix) - FDA-cleared, portable, widely used clinically; uses AI-guided eye tracking; extended study up to 20 minutes
- Scotopic Sensitivity Tester-1 (LKC Technologies) - validated against Goldmann-Weekers
- Twilight device (Evoq Technologies) - Class I FDA-registered, does not require a darkroom
Duration: Typically 20-30 minutes
3. Electroretinogram (ERG) - Most Objective Test
ERG records electrical responses of the retina to light flashes using corneal electrodes. It is a key investigation for nyctalopia with a suspected structural/hereditary cause.
ERG protocol for nyctalopia:
| Response | Stimulus | What it Tests |
|---|
| Scotopic dim flash (rod-only) | Dim blue flash after dark adaptation | Pure rod function |
| Scotopic bright flash (mixed rod-cone) | Bright white flash after dark adaptation | Combined rod-cone response |
| Photopic single flash | Flash in light-adapted state | Cone function |
| Photopic 30 Hz flicker | Flickering light | Cone-specific response |
Key waveforms:
- a-wave: Photoreceptor (outer retinal) response
- b-wave: Inner retinal (bipolar/Muller cell) response
- Oscillatory potentials: Seen on the ascending b-wave; reflect inner retinal integrity
Findings in nyctalopia:
- Retinitis pigmentosa: Markedly reduced or extinguished rod responses; secondary cone depression as disease progresses - per Harrison's Principles of Internal Medicine
- Gyrate atrophy: Abnormal to nonrecordable ERG - per Wills Eye Manual
- Choroideremia: Markedly reduced ERG
- Congenital stationary night blindness (CSNB): Characteristic electronegative ERG (a-wave > b-wave) or Schubert-Bornschein pattern
- Vitamin A deficiency: Reduced rod ERG, improves with supplementation
4. Visual Field Testing (Perimetry)
Used to detect peripheral field defects associated with nyctalopia causes:
- Goldmann Kinetic Perimetry or Humphrey Field Analyzer - detect ring scotoma, peripheral field constriction
- In retinitis pigmentosa: ring scotoma progressing to tunnel vision
- In gyrate atrophy and choroideremia: progressive peripheral field loss
- Per StatPearls/NCBI, visual field testing with ERG and clinical history are central to diagnosing RP
5. Fundoscopy (Ophthalmoscopic Examination)
Direct and indirect ophthalmoscopy may reveal:
| Finding | Condition |
|---|
| Bone spicule pigmentation, attenuated arterioles, disc pallor | Retinitis pigmentosa |
| Scalloped RPE/choriocapillaris atrophy (midperiphery) | Gyrate atrophy |
| Total RPE and choriocapillaris absence | Choroideremia |
| Bitot's spots on conjunctiva, dry eye | Vitamin A deficiency |
| Mizuo phenomenon (golden fundal sheen in light, normal in dark) | Oguchi disease (CSNB variant) |
| Drusen-like deposits, confluence along arcades | Sorsby fundus dystrophy |
6. Slit-Lamp Examination
- Evaluates for cataracts (a common cause of night vision reduction), keratoconus, corneal disease
- Also detects posterior subcapsular cataract seen in gyrate atrophy
7. Ancillary / Laboratory Tests
| Test | Purpose |
|---|
| Serum vitamin A (retinol) | Vitamin A deficiency (most common nutritional cause worldwide) |
| Plasma ornithine level | Gyrate atrophy (10-20x elevated; lysine decreased) |
| Genetic/molecular testing | Rhodopsin mutations (RP), CHM gene (choroideremia), OAT gene (gyrate atrophy) |
| Fundus autofluorescence (FAF) | Maps RPE integrity; abnormal in dystrophies |
| OCT (Optical Coherence Tomography) | Retinal layer thinning, photoreceptor loss |
| Fluorescein angiography (IVFA) | If ornithine level not markedly elevated in gyrate atrophy |
| CBC, LFTs, zinc level | Zinc deficiency can cause nyctalopia |
8. Paradoxic Pupillary Response
In congenital stationary night blindness (CSNB), the pupil paradoxically constricts initially in darkness (due to absence of rod-mediated ON-bipolar cell input). This can be elicited at the bedside with a swinging flashlight in dim conditions and is a useful clinical clue.
Summary: Practical Approach
Suspected Nyctalopia
↓
History + Fundoscopy + Slit-lamp
↓
Dark Adaptometry (quantify functional deficit)
↓
Full-field ERG (distinguish rod vs cone vs combined dysfunction)
↓
Visual Fields (Goldmann/Humphrey)
↓
Labs: Vitamin A, ornithine, zinc; genetic testing if hereditary
↓
OCT / FAF / IVFA as indicated
Sources: Wills Eye Manual (p. 888-889), Harrison's Principles of Internal Medicine 22E (p. 275), Bradley & Daroff's Neurology in Clinical Practice,
NCBI StatPearls - Night Vision Physiology